Lake Street Advisors Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$38.2K Hold
22,762
﹤0.01% 636
2024
Q3
$64.9K Hold
22,762
﹤0.01% 610
2024
Q2
$53.3K Hold
22,762
﹤0.01% 583
2024
Q1
$66.9K Hold
22,762
﹤0.01% 598
2023
Q4
$68.1K Sell
22,762
-4,828
-17% -$13.8K ﹤0.01% 582
2023
Q3
$87K Hold
27,590
0.01% 263
2023
Q2
$107K Sell
27,590
-1,349
-5% -$3.89K 0.01% 249
2023
Q1
$80K Sell
28,939
-11,280
-28% -$23.7K ﹤0.01% 248
2022
Q4
$72K Buy
+40,219
New +$77.6K ﹤0.01% 245

Other funds holding NAUT

Lake Street Advisors Group's NAUT Position: Q4 2024 in Review

Lake Street Advisors Group held its Nautilus Biotechnolgy (NAUT) position steady in Q4 2024 at 22,762 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Lake Street Advisors Group first reported a position in NAUT in Q4 2022 and has held it in 9 quarters since. The position peaked at $107K in Q2 2023. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

  • Lake Street Advisors Group held 22,762 shares of Nautilus Biotechnolgy worth $38.2K as of Q4 2024.
  • Lake Street Advisors Group left its Nautilus Biotechnolgy share count unchanged in Q4 2024.
  • Nautilus Biotechnolgy made up ﹤0.01% of Lake Street Advisors Group's portfolio in Q4 2024, its #636 holding.
  • Lake Street Advisors Group first reported a position in Nautilus Biotechnolgy in Q4 2022 and has held it in 9 quarters since.
  • Lake Street Advisors Group's Nautilus Biotechnolgy position peaked at $107K in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.